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Abstract
Background: Myocardial infarction (MI) is partly due to myocardial cell damage caused by hypoxia. 
MicroRNAs (miRNAs) have been proved to be closely related to the development and progression of 
many cardiovascular diseases. This study investigated the role of miR-145 in cardiomyocytes under 
hypoxic condition.
Methods: The quantitative real-time polymerase chain reaction (qRT-PCR) was performed to test 
miR-145 expression in H9c2 cells with hypoxia-inducible factor (HIF)-a abnormal expression under 
hypoxic condition. The 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyltetrazolium bromide (MTT), Tran-
swell assay and flow cytometry were used to investigate the effects of miR-145 on cell viability, migration 
and apoptosis under normoxic or hypoxic condition, respectively. Meanwhile, reactive oxygen species 
(ROS) content in hypoxic H9c2 cells was analyzed. Western blotting was used to explore the potential 
mechanism of miR-145 protective effects on cardiomyocytes. Expression levels of miR-145 and SGK1 
in rat MI model were also assessed.
Results: Results showed that miR-145 was upregulated in H9c2 and HL-1 cells under hypoxic condi-
tion, which was promoted by HIF-1a. MiR-145 overexpression enhanced cell viability and migration 
under normoxic condition. Under hypoxic condition, miR-145 overexpression promoted cell viability, 
inhibited apoptosis and ROS activity. Western blotting results proved that miR-145 overexpression 
inhibited the activation of apoptotic related factors, and promoted activation of PI3K/AKT signaling 
pathway via SGK1 upregulation. Expression levels of miR-145 and SGK1 were both upregulated in 
rat MI models.
Conclusions: HIF-1a could induce miR-145 upregulation in hypoxic H9c2 and HL-1 cells. MiR-145 
protected H9c2 cells against hypoxic damage. SGK1 upregulation and activated PI3K/AKT may have 
participated in the protective effects of miR-145 on cardiomyocytes. (Cardiol J 2018; 25, 2: 268–278)
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Introduction
Myocardial infarction (MI) is one of the lead-
ing causes of morbidity and mortality worldwide. 
Cardiac hypoxia is recognized as one of the main 
problems for cardiac repair after MI [1]. The cur-
rent conventional MI treatments including drug 
therapy, surgery and interventional therapy, can 
only alleviate the occurrence of heart failure to 
some extent. Recently, gene therapy in cardiovas-
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cular disease have achieved initial results. It is well 
known that genetic, environmental, and epigenetic 
factors affect the development of atherosclerosis 
and MI. Many genetic and epigenetic factors which 
are related with cardiovascular diseases, such as 
DNA methylation of Aryl hydrocarbon receptor 
repressor, interleunkin-1 reporter antagonist gene, 
inhibitor of kappa B-like protein gen polymor-
phisms, oxidative stress genes and others were 
investigated [2–5]. The genetic or epigenetic fac-
tors were believed to play important roles in the 
development of MI, suggesting that molecular 
level study might aid in the understanding of MI. 
Many studies have confirmed that microRNAs 
(miRNAs) expression was aberrant after the acute 
MI, which were involved in the pathophysiology of 
MI through post-transcriptional regulation effect [6]. 
Therefore, miRNAs were expected to be the novel 
biochemical markers and therapeutic targets for 
treatment of MI.
MiRNAs are small non-coding RNAs which 
regulate gene expression by either degradation 
or translational repression of a target mRNA at 
the post-transcriptional level. They are implicated 
in regulating diverse cellular processes, such as 
proliferation, differentiation, development, and 
cell death [7, 8]. Recent reports showed that the 
levels of individual miRNAs and specific miRNAs 
signatures were linked to the diagnosis and prog-
nosis for various types of human cancers, including 
chronic lymphocytic leukemia, breast, stomach, 
colon, pancreas and bladder cancers and includes 
other cancers as well [9, 10]. It has been verified 
that miRNAs were related with human body micro-
environments, such as hypoxia. And many hypoxic-
regulated miRNAs have been identified [11]. For 
instance, miR-210, miR-155, miR-372/373, and 
miR-10b were all found to be upregulated [12–14], 
whereas miR-20b and miR-200b were found to be 
down-regulated in response to hypoxia [15, 16]. 
However, the exact roles of miRNAs in MI have 
as yet not been completely understood.
In recent years, miRNAs have been suggested 
as candidates in the treatment of MI-induced car-
diac remodeling for their ability to regulate the 
expression levels of genes that govern the process 
of adaptive and maladaptive cardiac remodeling [17, 
18]. One study has confirmed that after MI in mice, 
miRNAs markedly stimulated cardiac regenera-
tion and almost completed the recovery of cardiac 
functional parameters [19]. MiRNAs were believed 
to hold great promise for the treatment of cardiac 
disease which was caused by cardiomyocyte loss.
This study aimed to investigate the role of 
miR-145 in cardiomyocytes under hypoxic condi-
tion. Here, the miR-145 expression in hypoxic 
H9c2 and HL-1 cells was tested, and its relation-
ship with hypoxia-inducible factor 1a (HIF-1a) 
expression in H9c2 cells was assessed. The ef-
fects of miR-145 on cell bioactivity, cell response 
to hypoxia and the underlying mechanisms were 
also investigated.
Methods
Cell culture
The rat cardiomyocyte-derived cell line H9c2 
and mouse cardiac muscle cell line HL-1 were 
obtained from American Type Culture Collection 
(ATCC, Rockefeller, Maryland, USA). Cells were 
cultured in high glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM, GIBCO) supplemented 
with 10% (v/v) fetal bovine serum (FBS, Sijiqing, 
Hangzhou, China) and incubated under normoxia 
condition (21% O2) in a standard CO2 incubator, 
or hypoxic condition (3% O2) by using a hypoxic 
workstation (Ruskinn Technology Limited, West 
Yorkshire, UK) to analog cells hypoxia.
Quantification of miR-145 expression
The miR-145 expression was evaluated by 
quantitative real-time polymerase chain reaction 
(qRT-PCR) with Power SYBR Fast PCR Master 
Mix and step-one plus real-time PCR machine 
(Applied Biosystems, Foster City, CA) as described 
previously [20]. U6 was used as an internal control. 
All reactions were performed in duplicate. Expres-
sion levels of miRNA were quantified employing 
the 2−DDCt relative quantification methods.
Cell transfection
The recombinant vector pc-DNATM 3.1(+) -HIF-1a 
with full-length of HIF-1a cording sequences or 
empty vector as its negative control (Thermo 
Fisher Scientific) were transfected into cells, 
respectively. The siRNA against HIF-1a was 
purchased from Santa Cruz Biotechnology (sc-
35561, Santa Cruz, CA). HIF-1a antibody (C-19) 
(sc-8711, Santa Cruz, CA) which was confirmed 
as no silencing double-stranded RNA, was used as 
a control for siRNA experiments. SGK1 silenced 
by SGK1 siRNA (sc-33774, Santa Cruz, CA) was 
performed by the same experimental protocol 
[21]. For miRNA transfection, cells were trans-
fected with miR-145 mimic, miR-145 inhibitor and 
negative miRNA control (scramble) (GenePharma, 
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Shanghai, China). All the transfections were per-
formed by using Lipofectamine 3000 (Invitrogen 
Life Technologies, Carlsbad, CA, USA) according 
to the manufacturer’s instructions. 
Cell viability assay
After transfection with either miR-145 mimic, 
inhibitor, or SGK1 siRNA, H9c2 cells were exposed 
to normoxic or hypoxic conditions for 48 h and 
then cell viability was assessed by using a 3-(4, 
5-dimethyl-2-thiazolyl)-2, 5-diphenyltetrazolium 
bromide (MTT) colorimetric assay according to 
the standard method. In brief, cells were seeded 
in 96-well culture plates and incubated for 1–4 
days. Then MTT (20 µL/well, Sigma, St. Louis, 
MO, USA) was added to each well. Cells were 
incubated for another 4 h at 37°C. Then 150 µL of 
dimethyl sulfoxide (DMSO, Sigma, USA) was added 
to each well and the plates were shaken for 10 min. 
Each experiment was performed in triplicate. The 
absorbance of each well was measured at 570 nm 
(OD570) with a 680 microplate enzyme-linked 
immunosorbent assay (ELISA) reader (Bio-Rad 
Laboratories, Hemel Hempsted, UK). 
Cell migration assay
Under normoxic conditions, H9c2 cells mi-
gration was determined after transfection with 
miR-145 mimic or inhibitor by using a modi-
fied two-chamber with 8.0 µm pore membranes 
(Greiner 662638). After transfection, cells were 
resuspended in 200 µL of serum-free culture me-
dium and seeded onto the upper compartments of 
24-well transwell culture chamber. The low com-
partment was added 600 µL of complete culture 
medium. Then cells were incubated at 37°C for 12 h 
and fixed by 4% methanol (NIST, USA) for 30 min. 
Non-transferred cells were removed from the 
upper surface of the filter carefully with a cotton 
swab. Traversed cells in the lower were stained 
with 0.1% crystal violet for 20 min and counted 
under an optical microscope (Leica Microsystems, 
Wetzlar, Germany).
Cell apoptosis assay
Flow cytometry analysis was performed to 
identify and quantify the apoptotic cells after 
miR-145 transfection under hypoxic condition, 
following assay by using Annexin V-FITC/PI ap-
optosis detection kit (Beijin Biosea Biotechnology, 
Beijing, China) according to manufacturer’s recom-
mendations. After 48 h of hypoxia administration, 
cells were collected, washed with PBS and then 
incubated with 10 µL of Annexin V-FITC and 5 µL 
of PI for 30 min at room temperature in the dark. 
Apoptotic cells were measured by Epics XL flow 
cytometer (Beckman Coulter, USA) [22]. 
Reactive oxygen species (ROS) assay
The miR-145 modified cells under hypoxic 
condition were seeded on 6-well plates, washed 
twice with PBS, and cultured in serum-free cul-
ture medium with 10 µM 2, 7-dichlorofluorescein 
diacetate (DCFH-DA) for 20 min at 37°C under 
dark conditions. Then cells were collected and 
suspended within 500 µL PBS, and fluorescent 
intensities were measured by using a flow cy-
tometer at 488 nm excitation and 521 nm emis-
sion [23].
Rat MI model
Surgical MI was induced in 6 week old male 
Sprague–Dawley rats (Charles River Laboratories 
International. Inc., Wilmington, MA, USA). Briefly, 
rats were anesthetized with isoflurane, intubated 
and ventilated with a rodent ventilator (Euthanex 
Corporation, Allentown, PA, USA). The left ante-
rior descending coronary artery was ligated with 
silk ligature at a point 1–2 mm distal to the edge 
of the left atrium. Evidence of MI was confirmed 
by ST segment elevation and the appearance of 
Q wave on an electrocardiogram. After surgery, 
rats were randomly assigned into two experimental 
groups: sham operated (rat chest opened/closed 
without ligation, n = 5); MI (rat chest opened/
closed with ligation, n = 5). The animals were then 
placed on a heating pad and observed every 15 min 
until fully recovered from anesthesia as indicated 
by the ability to maintain sternal recumbency and 
moving normally. All animal handing protocols 
were approved by the Institutional Animal Care 
and Use Committee of Linyi People’s Hospital. 
Buprenorphine was given to the animals before 
surgery to prevent residual pain during surgery 
and after surgery to relieve pain and stress during 
recovery from anesthesia. Each animal was allowed 
a minimum of 4 weeks of recovery. The animals were 
then euthanized by an overdose of Kcl (2 mg/kg) 
injection via the tail vein under gas anesthesia. 
Frozen left ventricular samples used for miR-145 
or SGK1 expression level analysis were homog-
enized in Trizol (Invitrogen Life Technologies, 
Strathclyde, UK) according to the manufacturer’s 
instructions.
Western blot assay
The protein expression levels in miR-145 
and/or SGK1 siRNA modified H9c2 cells in this 
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study were detected by Western blotting. The 
protein samples were extracted by lysis buffer 
(Beyotime Biotechnology, Shanghai, China) sup-
plemented with protease inhibitors (Roche, Guang-
zhou, China), and the BCATM Protein Assay Kit 
(Pierce, Appleton, WI, USA) was used for protein 
quantification. Then equal amounts of samples 
were separated by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) 
gels and then transferred onto PVDF membranes 
(Millipore, Billerica, MA, USA) as described pre-
viously [24]. Specific antibodies against HIF-1a 
(ab179483); Caspase-9 (ab2014); cleaved Cas-
pase-9 (ab2325); Caspase-3 (ab13847); cleaved 
Caspase-3 (ab49822); poly ADP ribose polymerase 
(PARP, ab32138); cleaved-PARP (ab32064); B-cell 
lymphoma-2 (Bcl-2, ab32124); serum and gluco-
corticoid-regulated kinase 1 (SGK1, ab59337); 
PI3K (ab189403); phosphorylated PI3K (p-PI3K, 
ab182651); AKT (ab8805); phosphorylated AKT 
(p-AKT, p308, ab38449; p473, ab81283); glycer-
aldehyde-3-posphate dehydrogenase (GAPDH) 
(ab8245) (all 1:1,000, Abcam, USA) were used along 
with appropriate fluorescent secondary antibodies 
(Santa Cruz biotech).
Statistical analysis
Data were presented as mean ± standard 
deviation (SD). The significance of differences in 
mean values within and between multiple groups 
was evaluated using an ANOVA followed by a Dun-
can’s multiple range test. Student’s t-test was used 
to evaluate statistical significance of differences 
between two groups. P < 0.05 was considered 
statistically significant.
Results
MiR-145 expression was up-regulated  
in hypoxic cells
The miR-145 expression assay was performed 
by qRT-PCR and results showed that miR-145 ex-
pression was significantly increased with time in 
both H9c2 (Fig. 1A) and HL-1 cells (Fig. 1B) under 
hypoxic condition (3% oxygen), compared with the 
normal group (p < 0.05 or p < 0.01). It suggested 
that hypoxia could induce miR-145 upregulation 
and this induction for miR-145 expression might 
be in a time-dependent manner.
HIF-1a promoted miR-145 expression  
in hypoxic H9c2 cells
Hypoxia-induced miRNA expressions have 
been reported to be associated with HIF-1a activity 
in several cell lines [25, 26]. Here, the relationship 
between miR-145 expression and HIF-1a exog-
enous expression or gene silence was analyzed. As 
shown in Figure 2A and 2B, efficiency of HIF-1a 
up-regulation and inhibition were confirmed by 
Western blot analysis compared with the trace 
amounts of HIF-1a expression under normoxic 
condition. More importantly, miR-145 expression 
was positively related with HIF-1a expression 
under hypoxic condition (p < 0.05, Fig. 2C). It 
suggested that in hypoxic H9c2 cells, miR-145 
expression was positively regulated by HIF-1a.
Figure 1. Expression of miR-145 in H9c2 cells (A) and HL-1 cells (B) which were cultured under normoxic condition 
(21% O2) or hypoxic condition (3% O2) for 24–48 h. The mRNA expression levels of miR-145 were measured by 
qRT-PCR. U6 acted as an internal control; N — normoxia; H — hypoxia; qRT-PCR — quantitative real-time polymerase 
chain reaction; *p < 0.05; **p < 0.01.
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miR-145 enhanced cell viability  
and migration of H9c2 cells
First, to determine the efficiency of miR-
-transfection, the expression of miR-145 in H9c2 
cells after transfection with miR-145 mimic, miR-
-145 inhibitor, or scramble control were measured. 
The results in Figure 3A showed that transfection 
with miR-145 mimic increased the expression 
levels of miR-145 in H9c2 cells under normoxic 
condition, and miR-145 expression was decreased 
in the miR-145 inhibitor transfected H9c2 cells. 
Under normoxic condition, MTT results 
(Fig. 3B) showed that after transfection with miR-
145 mimic, the H9c2 cell viability were significantly 
increased compared to the control group after 
3 and 4 days (p < 0.01). However, transfection with 
miR-145 inhibitor decreased cell viability (p < 0.05 
or p < 0.01). The results of migration assay 
(Fig. 3C, D) showed that, cell migration was 
significantly elevated after miR-145 mimic trans-
fection (p < 0.05), while it was decreased by 
miR-145 inhibitor transfection (p < 0.05) under 
normoxic condition. These results suggested that 
miR-145 expression level was positively related 
with H9c2 cell viability and migration under nor-
moxic condition.
miR-145 enhanced cell viability  
and migration while inhibited  
apoptosis of hypoxic H9c2 cells
As shown in Figure 4A, H9c2 cells viability 
was reduced under hypoxic condition. Follow-
ing with miR-145 mimic transfection, the cells 
viability was significantly increased (p < 0.01), 
whereas it was decreased after miR-145 inhibitor 
transfection compare with negative control (p < 
0.05). ROS assay results (Fig. 4B) suggested that 
in miR-145 mimic treated cells, the content of ROS 
was reduced compared with negative control (p < 
0.05), while miR-145 inhibitor increased the ROS 
content (p < 0.05). The flow cytometry analysis 
results in Figure 4C showed that the apoptotic cells 
rate was significantly decreased after transfection 
with miR-145 mimic and elevated in miR-145 in-
hibitor transfected cells compared with negative 
control under hypoxic condition (p < 0.05). Then, 
expression levels of apoptotic related factors by 
Western blotting were examined. As shown in 
Figure 4D, after hypoxia administration, expres-
sion levels of cleaved form of Caspase-9, Caspase-3 
and PARP in H9c2 cells were increased. However, 
their expressions were significantly decreased 
after miR-145 mimic transfection and increased 
Figure 2. Expression of miR-145 was positively related with HIF-1a expression in H9c2 cells under hypoxic condition. 
A. The HIF-1a expression in H9c2 cells transfected with recombinant vector pc-DNATM 3.1(+) -HIF-1a under normoxic 
condition; B. Expression of HIF-1a in H9c2 cells after transfection with HIF-1a siRNA under normoxic condition. 
Glyceraldehyde-3-posphate dehydrogenase (GAPDH) acted as an internal control; C. Expression levels of miR-145 
in H9c2 cells after transfection with heterogeneous overexpression of HIF-1a or HIF-1a siRNA under normoxic or hy-
poxic condition were measured by qRT-PCR. U6 acted as an internal control; N — normoxia; H — hypoxia for 48 h; 
NC — HIF-1a negative control; qRT-PCR — quantitative real-time polymerase chain reaction; *p < 0.05.
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by miR-145 inhibitor transfection. The changes in 
Bcl-2 expressions were reversed and compare with 
these three factors above after miR-145 transfec-
tions. It suggested that miR-145 could inhibit the 
apoptosis of hypoxic H9c2 cells. Taken together, 
these data indicate that miR-145 could affect H9c2 
cells bioactivity and protect H9c2 cells against the 
hypoxia injury.
MiR-145 was positively related with  
the expression of SGK1 and the  
activation of PI3K and AKT
To further investigate the protective effects 
of miR-145 on H9c2 cells under hypoxic condi-
tion, changes of SGK1 were detected by Western 
blotting. MiR-145 mimic transfection showed the 
upregulation effect on SGK1 expression in H9c2 
cells under both normoxic and hypoxic conditions, 
while miR-145 inhibitor transfection decreased 
expression of SKG1 compared with that in the 
negative control (Fig. 5A, B). In addition, results in 
Figure 5C showed that simultaneous transfection 
with miR-145 mimic and SGK1 siRNA inhibited 
SGK1 and Bcl-2 expressions under hypoxia, while 
increased cleaved-Caspase-3, cleaved-Caspase-9 
and cleaved-PARP expressions compared with 
miR-145 mimic transfection alone. It suggested 
that the effects of miR-145 on H9c2 cells under 
hypoxic condition might be at least in part via 
modulation of SGK1 and thus protecting H9c2 cells 
against apoptosis.
To further investigate the potential mecha-
nisms about miR-145 protective effect, expression 
levels of p-AKT, p-PI3K and Bcl-2 after miR-145 
mimic transfection alone, or co-transfection with 
SGK1 siRNA under normoxic condition were also 
detected. As shown in Figure 5D, miR-145 mimic 
transfection increased the expression of SGK1, and 
also increased the phosphorylation levels of AKT 
and PI3K. However, after SGK1 siRNA transfec-
Figure 3. miR-145 upregulation increased cell viability and migration of H9c2 cells. A. The relative expression of miR-
145 in H9c2 cells was measured by qRT-PCR. U6 acted as an internal control; B. Cell viability was determined by MTT 
assay; C. The relative migration of transfected cells was measured by Transwell assay; D. Pictures of cell migration 
assay results. Transferred cells were strained with 0.1% crystal violet; N — normoxia; H — hypoxia for 48 h; NC — 
miR-145 negative control; MTT — 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyltetrazolium bromide; qRT-PCR — quanta-
tive real-time polymerase chain reaction; *p < 0.05; **p < 0.01; ***p < 0.001.
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tion, even with miR-145 mimic transfection, the 
phosphorylated AKT and PI3K expressions were 
decreased, as well as the changes of Bcl-2 expres-
sions. Therefore, it could be  be infered that SGK1 
and PI3K/AKT signaling pathway might also be 
related with the protective effect of miR-145 on 
hypoxic H9c2 cells.
Expression levels of miR-145 and SGK1 
were significantly increased in ischemia 
models in vivo
To verify the regulation mechanism of miR-145 
in H9c2 cells under hypoxic condition, the in vivo 
detections about SGK and miR-145 expression 
levels were also performed by using a rat MI model. 
Results in Figure 6 show that miR-145 expression 
level was significantly increased in MI models 
compare with that in sham group (p < 0.05). As 
shown in Figure 6B and 6C, expression of SGK1 
was also increased in both mRNA and protein levels 
compared with the sham group (p < 0.01 for mRNA 
level). These results suggested that upregulations 
of miR-145 and SGK1 were observed in MI models 
in vivo. Combined with the above results, it sug-
gested that SGK1 signaling might be parallel with 
miR-145 effect on MI in vivo.
Discussion
In this study, simulative hypoxic myocardial 
model in vitro by using H9c2 cell line was con-
structed, and it was found that miR-145 expression 
was increased by HIF-1a overexpression. Mean-
while, miR-145 mimic transfection promoted cell 
viability and migration, while inhibited apoptosis 
under hypoxic condition, suggesting that miR-145 
might protect H9c2 cells against hypoxic damage. It 
was also found that SGK1 and main factors in PI3K/ 
Figure 4. Effects of miR-145 on H9c2 cells under normoxic or hypoxic condition after transfection with miR-145 mimic 
or miR-145 inhibitor; A. Cell viability was determined by MTT assay; B. Quantitative analysis of reactive oxygen spe-
cies content by measuring the fluorescent intensities of 2, 7-dichlorofluorescein diacetate; C. The apoptotic cells rate 
was detected by flow cytometry; D. Expression of apoptosis related factors were measured by Western blotting; 
N — normoxia; H — hypoxia for 48 h; GAPDH — glyceraldehyde-3-posphate dehydrogenase; PARP — poly ADP 
ribose polymerase; NC — miR-145 negative control; *p < 0.05; **p < 0.01.
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/AKT signaling pathway might also be involved in 
the protective effects of miR-145 on H9c2 cells 
under hypoxic condition. MiRNAs regulation has 
been found to be implicated in many cardiovascular 
diseases. It has been demonstrated that miRNAs 
play an important role in the development of pul-
monary arterial hypertension which were induced 
by chronic hypoxia [27]. However, miRNAs regula-
tion and response to microenvironmental factors 
were relatively little known. These results might 
provide a basic understanding about the effects of 
miR-145 on hypoxic cardiomyocytes. 
Since it was first reported that the expres-
sion of miRNA panel could be induced by hypoxia 
[28], numerous studies about hypoxia-regulated 
miRNAs have emerged, including miR-26, miR-
-107 and miR-210 [29]. Hypoxia is an essential 
feature of the MI microenvironment, but the 
molecular mechanisms which are responsible for 
the hypoxic survival of cardiomyocytes are not 
fully characterized. It has been shown that hypoxia 
can leave a specific mark on miRNA profiles in 
a variety of cell types, with a critical contribu-
tion of HIF [28]. Besides, HIF-1 is proved to be 
a major regulator of hypoxic response after MI 
[30]. In the present study, compared hypoxic cells 
with normoxic cells, it was found that hypoxia 
induced the upregulation of miR-145, and the 
miR-145 upregulation relied on HIF-1a expres-
sion. These results implied that miR-145 might be 
a hypoxia-regulated miRNA which was dependent 
on HIF-1a.
MiR-145, as an important tumor suppressor, 
shows a significant contribution to tumor patho-
genesis in distinct cancer types. It has been proved 
that miR-145 can induce cancer cell apoptosis and 
is considered to be an important target for cancer 
therapy [31, 32]. In the present study, results 
Figure 5. MiR-145 affected SGK1 expression and activation of PI3K/AKT signaling in H9c2 cells. The protein expres-
sions were measured by Western blotting. A. Protein immunofluorescence of SGK1 expression in miR-145 mimic or 
miR-145 inhibitor transfected H9c2 cells under normoxic condition; B. SGK1 expression in miR-145 transfected H9c2 
cells under hypoxic conditions; C. Protein immunofluorescence of apoptosis related factors in H9c2 cells after been 
treated with miR-145 mimic and/or SGK1 siRNA under hypoxic condition; D. Protein immunoblots of SGK1, p/t-AKT, 
p/t-PI3K and Bcl-2 in H9c2 cells after the treatments of miR-145 mimic, and/or SGK1 siRNA under normoxic condition. 
Glyceraldehyde-3-posphate dehydrogenase (GAPDH) acted as an internal control; N — normoxia; H — hypoxia for 
48 h; NC — miR-145 negative control; C-Caspase-9 — cleaved Caspase-9; C-Caspase-3 — cleaved Caspase-3; PARP 
— poly ADP ribose polymerase; C-PARP — cleaved PARP; AKT — protein kinase B; p-AKT — phosphorylated AKT; 
PI3K — phosphatidylinositol-3 kinase; p-PI3K — phosphorylated PI3K.
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suggestthat overexpression of miR-145 promoted 
H9c2 cells viability and migration under normoxic 
condition, as well as under hypoxic condition. MiR-
-145 overexpression significantly advanced cell 
viability, reduced apoptosis and damage to H9c2 
cells caused by hypoxia, suggesting that miR-145 
could protect H9c2 cells against hypoxia damage, 
more than a hypoxia-regulated miRNA.
MiR-145 has been proved to be related with 
apoptosis in urothelial carcinoma cell lines char-
acterized by caspase activation [33]. It was well 
known that caspase family proteases, are gener-
ally an inactive form in normal cells and play an 
important role in the mechanism of apoptosis [34]. 
Herein was examined the relationship between 
miR-145 expression and apoptosis related factors 
under hypoxic condition. Results showed that 
miR-145 overexpression inhibited the expression 
levels of cleaved-Caspase-9, cleaved-Caspase-3 
and cleaved-PARP while increased Bcl-2 expres-
sion. These results further indicated that miR-145 
upregulation might protect cells against cellular 
apoptosis during hypoxia.
SGK1, as a kinase associated with cell prolif-
eration and apoptosis, is a downstream effector of 
PI3K implicated in pro-survival mechanisms. Ac-
cording to previous research, inhibition of SGK1 
could enhance miRNA-induced apoptosis in cancer 
cells [35]. Indeed, SGK1 is also shown to enhance 
colon tumor cell migration via vinculin de-phos-
phorylation [36]. These findings imply a possible 
cross connection of SGK1 with miRNA regulation, 
signaling pathway and cell survival. The present 
findings showed that miR-145 expression was posi-
tively related with SGK1 expression in vitro and in 
vivo. While combining with the SGK1 inhibition, 
the miR-145 mimic inhibition effect on expressions 
of apoptosis related factors were significantly re-
versed. For the main factors in PI3K/AKT signaling 
pathway, miR-145 overexpression was positively 
correlated with the activation of PI3K/AKT signal-
ing, and it might be via SGK1 expression. Thus, the 
effects of miR-145 on H9c2 cells against hypoxia 
might be associated with SGK1. SGK1 and PI3K/ 
/AKT might also be participating in providing 
a survival advantage to H9c2 cells.
Conclusions
In conclusion, it was demonstrated that ex-
pression of miR-145 could be regulated by HIF-1a 
in cardiomyocytes under hypoxic condition. Fur-
ther confirmation of the targeting effect of miR- 
-145 could provide strong evidence for miR-145 as 
a biomarker for clinical diagnosis of MI. In addition, 
miR-145 upregulation could improve cell survival 
under hypoxic condition, and inhibited apoptosis 
via regulating the expressions of apoptosis related 
factors. SGK1 and PI3K/AKT activation might also 
be involved in miR-145 protective effects on MI. 
All these findings implied that hypoxia-induced 
miR-145 upregulation was related with cell pro-
Figure 6. Expression levels of miR-145 and SGK1 were 
significantly increased in rat MI model in vivo. The MI 
model was established in rats by using ligation on left 
anterior descending coronary artery. The relative ex-
pression levels of miR-145 (A) and SKG1 mRNA (B) 
in simulated rat MI model in vivo were measured by 
qRT-PCR; C. Protein expression of SGK1 in simulated 
rat MI model in vivo was measured by western blotting. 
Glyceraldehyde-3-posphate dehydrogenase (GAPDH) 
acted as an internal control. Sham, sham operated (rat 
chest opened/closed without ligation, n = 5); MI, myo-
cardial infarction (rat chest opened/closed with ligation, 
n = 5); qRT-PCR — quantitative real-time polymerase 
chain reaction; *p < 0.05; **p < 0.01.
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tection. It might be worthwhile to validate the 
miR-145 protective effect against hypoxic-induced 
injury in the treatment of MI. This study might of-
fer a novel option for early diagnosis of MI.
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